Cortechs.ai | Understanding Change Data in LesionQuant 2.3

Understanding Change Data in LesionQuant 2.3

Did you know that the LesionQuant module offers lesion and brain structure change data for review?

Lesion and brain structure change data is available when a current and prior LesionQuant study have been processed and are available in the queue monitor. Change values of lesions are determined by using both 3D T1 and (2D or 3D) T2 FLAIR MRIs.

Morphometry Results
The change calculation of brain structures provides the difference between the current and prior scan brain volumes, percent of ICV, and normative percentile.

Cortechs.ai | Understanding Change Data in LesionQuant 2.3

Data from the prior study will also be included in the report for both lesions and brain volumes. Additionally, multi time-point-plotting displays the current and prior measurements on the same same report, allowing for ongoing patient evaluation with longitudinal tracking.

Lesion Results

  • Compare lesion count, volume and %ICV to prior scan
  • Review new and enlarging lesions, and the sum of the new and enlarging lesions
  • Evaluate where new and enlarging lesions are anatomically located, and examine the count of new lesions and the volume of new, enlarging and the sum of the new and enlarging lesions

Cortechs.ai | Understanding Change Data in LesionQuant 2.3

Cortechs.ai | Understanding Change Data in LesionQuant 2.3

 

Lesion Size Distribution Histogram
The histogram of lesion size distribution displays number of lesions within each lesion size bracket for current and prior scans. This data can characterize global lesion changes and provide an indication of disease progression.

Reproducibility and Comparison Best Practices
It is best practice to perform the current MRI on the same MRI scanner and series protocol as the prior MRI. If different scanners and/or protocols are used, caution should be taken when interpreting the results.

When patient data is already in the system
If an earlier scan for the patient has been processed by LesionQuant (same software version) and is available in the queue monitor, change volume images are automatically included in the output sent to the PACS/DICOM Viewer. The PatientID must match on both time points, and the StudyInstanceUID must match on the individual T1/FLAIR pair.

When patient data is no longer in the system or there has been a change in the software version from the prior scan
To obtain the change visualization, the user must reprocess the prior scan pair, then send the current scan pair for processing to receive the change analysis and volumes. The PatientID must match on both time points, and the StudyInstanceUID must match on the individual T1/FLAIR pair.

If the prior study is sent to LesionQuant for comparison reprocessing, it is important that the prior T1/FLAIR pair is processed completely before submitting the current T1/FLAIR pair.

More Resources

09/16/2025

OnQ Prostate for Focal Therapy

Read how OnQ Prostate supports focal therapy by personalizing prostate cancer care for patients while minimizing the risks associated with it.

09/03/2025

Reimbursement Considerations for OnQ Prostate and Category III CPT Codes 0648T & 0649T

Learn how Cat. III CPT codes 0648T and 0649T apply to OnQ™ Prostate, offering guidance for accurate reporting, reimbursement, and building evidence for coverage

09/02/2025

Maximizing the Value of Prostate MRI for the Urologist

Even with expert radiologists or AI models at hand, the challenge remains: how can urologists improve seeing and interpreting cancer?

08/18/2025

Why Bigger Normative Databases Mean Better Brain Imaging

NeuroQuant® 5.2 compares patient brain MRI volumes to over 7,000 healthy scans, giving clinicians clear, percentile-based context for better assessments.

08/07/2025

Navigating Reimbursement for NeuroQuant: Understanding CPT Codes 0865T & 0866T 

Let’s break down the latest category III CPT codes and example clinical use cases that illustrate their value.

07/31/2025

Precision Without the Pressure: Smarter Brain Tumor Monitoring

Learn about NeuroQuant Brain Tumor 2.0 and how it assists clinicians by providing objective quantification and analysis of tumor changes over time.
Scroll to Top